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Abstract 
Background: Transcatheter aortic valve implantation (TAVI) is an alternative therapy for 
surgically high-risk patients with severe aortic stenosis (AS). Although TAVI improves 
survival of patients with severe AS, the mechanism of this effect remains to be clarified. I 
investigated the effects of TAVI on left ventricular (LV) function and identified the 
predictive parameters for cardiac events after TAVI.  
Methods and results: I studied 128 patients with severe symptomatic AS who underwent 
TAVI. Echocardiographic assessments were performed before and after TAVI. In addition to 
the conventional echocardiographic parameters such as LV ejection fraction (LVEF) and LV 
mass index (LVMI), the LV global longitudinal strain (GLS) and early diastolic peak strain 
rate (SR_E) using two-dimensional speckle tracking echocardiography were also evaluated. 
All patients were assessed for clinical events including major adverse cardiac events and 
  
 
stroke according to Valve Academic Research Consortium-2 criteria. GLS, early diastolic 
peak velocity (eʹ), aortic regurgitation (AR) severity, and SR_E were significantly improved 
after TAVI. Thirteen patients had an event during the observational period of 591 days 
(median). Patients with events had worse GLS compared to those without events. 
Furthermore, receiver-operating curve analysis revealed that GLS was the strongest predictor 
for clinical events (p=0.009; area under the curve, 0.73).  
Conclusion: Preoperative LV dysfunction improved after TAVI and could predict cardiac 
events after TAVI. 
 
Introduction 
Aortic stenosis (AS) is a common valvular heart disease, and conventional surgical 
aortic valve replacement (SAVR) is the therapy of choice for the majority of patients. 
However, for patients considered to be at surgically high risk, transcatheter aortic valve 
implantation (TAVI) has emerged as a less invasive option than surgical valve replacement 
over the past decade. Several recent studies have shown the feasibility and safety of TAVI 
during short-term and mid-term follow-up periods [1-3]. Lefevre et al. reported that all-cause 
30-day mortality was lower in recent years and that there were significantly less major 
vascular complications, life-threatening bleedings, and major bleedings after TAVI compared 
to when TAVI was first introduced [3]. The early results are encouraging, with reported 
30-day mortality rates less than 10% and 1-year survival rates more than 70% [4-9]. 
Several studies have demonstrated an improvement in left ventricular (LV) systolic 
function assessed by LV ejection fraction (LVEF), tissue Doppler, and speckle tracking strain 
imaging in patients with severe AS after SAVR during mid-term and long-term follow-up 
[10-12]. Recent studies also demonstrated recovery of LVEF and global longitudinal strain 
(GLS) after TAVI [13]. Furthermore, another study reported that TAVI induces faster 
  
 
recovery of LV geometry and greater reduction of the estimated LV filling pressure than 
traditional SAVR [14].  
Recently, the ratio of global diastolic strain rate (SR) to mitral early diastolic velocity 
(E) (E/SR) was reported as a relatively novel parameter of LV relaxation and filling pressure 
[15]. Dahl et al. reported that the ratio of pre-operative E to early diastolic peak strain rate 
(SR_E; E/SR_E) was significantly associated with long-term post-operative survival and was 
superior to the E/early diastolic peak velocity (eʹ) ratio (E/eʹ) for patients with severe AS 
undergoing SAVR [16]. 
The aim of this study was to investigate the effect of TAVI on LV function and to 
identify echocardiographic predictors of clinical events after TAVI.  
 
 
Methods 
 
Study population 
From October 2013 to July 2016, I retrospectively studied patients who underwent 
transthoracic echocardiography before and after (within 7 days) TAVI using Vivid-E9 or 
Vivid-7 ultrasound machines (GE Healthcare). One hundred twenty-eight patients were 
included in the main outcome analysis; 18 were excluded due to clinical trial (n=17) or 
unanalyzable poor trace (n=1). Table 1 presents the clinical characteristics of the study 
subjects. The institutional Review Board of Keio University approved this retrospective, 
observational cohort study and the requirement to obtain informed consent was waived (IRB 
No. 20160249). The study was conducted in accordance with the guidelines of the 
Declaration of Helsinki.  
  
 
Echocardiography 
All patients underwent standard echocardiography using a Vivid-7 or Vivid-E9 
ultrasound system (GE Healthcare). Offline analyses were performed (EchoPAC; GE 
Healthcare) for all measurements. LV dimensions were obtained in the parasternal long axis 
with the M-mode cursor positioned just beyond the mitral leaflet tips, perpendicular to the 
long axis of the ventricle. LVEF was obtained using modified Simpson methods. LV mass 
index (LVMI) was calculated using the liner method (Cube formula). The mean transvalvular 
gradient was calculated using the Bernoulli formula. The aortic valve area was measured 
using the continuity equation. Early diastolic peak velocity (Eʹ) and late diastolic peak 
velocity (Aʹ) from Doppler tissue imaging were measured at the septal and lateral mitral 
annulus.  
 
Speckle tracking echocardiography 
LV myocardial longitudinal function was evaluated using two-dimensional speckle 
tracking echocardiography (2DSTE). Offline analysis was performed using semi-automated 
2D strain software (EchoPAC). First, the endocardial border was manually traced and the 
myocardial motion was tracked. The longitudinal strain and strain rate were measured in the 
apical long axis, 4-chamber, and 2-chamber views.  
Wang et al. demonstrated that the strain rate during isovolumetric relaxation (SR_IVR) 
and during early LV filling (SR_E) had strong correlations with the time constant of LV 
pressure decay, and that E/SR_IVR and E/SR_E were more accurate for estimating LV filling 
pressure than E/eʹ [15]. Therefore, we also measured SR_E using 2DSTE.  
The absolute value of the peak GLS was measured and the peak longitudinal strain rate 
during early diastole (SR_E) was calculated as an average of those measured in three views. 
  
 
Only the absolute values are referred to this study in all comparisons of GLS between groups 
according to the American Society of Echocardiography [17]. 
Twenty randomly selected patients were tested to determine the reproducibility of 
2DSTE. The interclass correlation coefficients for interobserver and intraobserver 
reproducibility for 2DSTE were 0.93 (95% confidence interval [CI], 0.87-0.97), and 0.95 
(95% CI, 0.93-0.97), respectively. 
 
Definitions of clinical outcomes 
Clinical events were pre-specified as the primary end points of death and hospitalization 
due to congestive heart failure and stroke according to the Valve Academic Research 
Consortium (VARC)-2 criteria. The follow-up period was 591 days (median). 
 
Statistical analysis 
Data are presented as mean value ± standard deviation (SD). Differences between 
groups were determined using the Student paired t test. Chi-square or Fisher exact tests were 
used to analyze the categorical data. I calculated the cumulative clinical events using the 
Kaplan-Meier method and compared the two curves using a log-rank test. 
In addition, the area under the curve (AUC) of the model was calculated using the 
generalized U statistic; p<0.05 was considered statistically significant. 
From the available information on echocardiographic parameters before TAVI, the 
following variables were of clinical interest in their relationship with clinical events : left 
ventricular diastolic dimension (LVDd), left ventricular systolic dimension (LVDs), 
Interventricular septum (IVS), posterior wall (PW), LVEF, LVMI, E, A, E/A, Dct, averaged 
e’, E/e’, aortic valve peak velocity, aortic valve mean pressure gradient, aortic valve area 
  
 
(AVA), GLS, SR_E and E/SR_E. These relationships were assessed through univariate 
logistic regressions of events. All statistical analyses were performed using JMP 11.0 
software (SAS Institute, Cary, NC, USA). 
 
 
Results 
Baseline characteristics of the study population are presented in Table 1. The mean age 
of the study population was 84±4.2 years and 65.6% of patients were female. Trans-femoral 
(TF)-TAVI was used in 113 cases, trans-apical (TA)-TAVI in 14 cases and direct-aortic 
(DA)-TAVI in 1 case. 
Baseline echocardiographic parameters and measurements obtained within 7 days after 
TAVI are presented in Table 2.  
At baseline, LV mass was increased but the LV wall thicknesses of the interventricular 
septum and posterior wall were within normal range. The mean preprocedural LVEF was 
62±13% and peak longitudinal GLS was -15±4.4%, indicating that LV longitudinal systolic 
function was impaired. Low eʹ and high E/eʹ indicated impaired LV relaxation and increased 
LV filling pressure before TAVI, respectively.  
Acute procedural success was achieved for all patients (100%). No patients required 
urgent cardiac surgery to manage complications.  
 
 
 
 
 
  
 
Effects of TAVI on echocardiographic parameters 
Table 2 also shows that the peak AV velocity (4.5±0.7 m/s vs. 2.2±0.4 m/s; p<0.0001) 
and mean pressure gradient (50±18 mmHg vs. 10±3.9 mmHg; p=0.0003) significantly 
decreased after TAVI. The parameters of LV relaxation including average eʹ (4.7±1.4 cm/s vs. 
5.2±1.7 cm/s; p<0.0001) and SR_E (0.78±0.34 /sec vs. 0.90±0.37 /sec; p<0.0001) also 
significantly improved after TAVI, in keeping with improved LV relaxation after TAVI. 
Furthermore, GLS was significantly improved (-15±4.4% vs. -16±4.3%; p<0.0001) after 
TAVI, while there was no significant change in LVEF before and after TAVI (62±13% vs. 
64±11%; p=0.063). In contrast, increased E/SR_E was unexpectedly observed after TAVI 
(121±67 cm vs. 127±79 cm; p<0.0001).  
 
Clinical events after TAVI 
    Thirteen patients had clinical events (2 cardiac deaths, 6 admissions due to heart failure, 
5 strokes) during the observational period of 591 days (median). Table 3 shows the clinical 
and echocardiographic characteristics before TAVI in patients with and without clinical 
events. Patients with clinical events had worse GLS (-11.6±1.2% vs. -15.1±0.4%; p=0.0061) 
compared to those without clinical events. During univariate regression analyses, only GLS 
(odds ratio [OR], 1.23; 95% CI, 1.05-1.45; p=0.004) was associated with MACE after TAVI 
(Table 4). Receiver-operating characteristic (ROC) curve analysis identified GLS of -10.6% 
(AUC, 0.73) as the best cut-off value for predicting clinical events after TAVI (Fig 1).  
Kaplan-Meier analysis revealed that freedom from events for patients with GLS  
≦ -10.6% occurred more often than it did for those with GLS > -10.6% (log-rank P = 
0.0003; Fig 2). 
 
  
 
Discussion 
The present study revealed that in patients with severe AS, TAVI improved LV diastolic 
function (eʹ and SR_E) and LV systolic function (GLS) within 1 week of intervention, and 
that pre-procedural GLS is a useful predictor for clinical events following TAVI.  
Improvements in LV diastolic function have been demonstrated to occur early after 
TAVI [18, 19]. Consistent with this study, several reports showed that there was an acute 
improvement in myocardial longitudinal systolic function measured by 2D strain analysis [18, 
20, 21]. However, to my knowledge, the present study is the first to demonstrate that 
pre-procedural GLS could predict the occurrence of clinical events after TAVI. 
 
Improvement in LV function after TAVI 
Wang et al. reported that SR_E was negatively correlated with the time constant of 
LV pressure decay and that it was stronger than Eʹ [15]. In this study, Eʹ and SR_E were 
significantly improved after TAVI, indicating that LV diastolic relaxation was ameliorated 
after TAVI, probably due to the reduction of the LV pressure overload. In contrast, E/SR_E 
and E/Eʹ, the parameters that correlated with LV filling pressure, unexpectedly worsened due 
to the increase in E wave velocity. Goncalves et al. previously reported that there was an 
increase in the E wave maximum velocity immediately after TAVI, and they speculated that 
this may be explained by alterations in pre-load or LV relaxation [19]. Other studies also 
reported that E/Eʹ as well as E/SR_E were not improved and were comparable to others, and 
that these parameters might not reflect the LV filling pressure immediately after TAVI.  
In this study, LV systolic function assessed by GLS also improved early after TAVI 
(within 1 week), although, there was no significant change in LVEF. Consistent with our data, 
Schastian et al. [21] reported that the radial strain, circumferential strain, and LVEF did not 
  
 
change significantly in all patients immediately after TAVI, but that there was an acute 
improvement in myocardial longitudinal systolic function measured by 2D strain analysis. 
They also speculated that GLS could reliably detect early regional changes of myocardial 
function after TAVI before benefits in LVEF were detectable [21]. This study suggested that 
not only diastolic function but also systolic function improved within 1 week after TAVI. 
 
Predictors of clinical outcomes after TAVI 
Numerous previous studies have assessed the value of myocardial deformation in 
predicting clinical outcomes of patients with severe AS [22, 23].
 
In this study, a worse 
pre-procedural GLS was significantly associated with clinical events after TAVI, implying 
that potential LV systolic dysfunction due to LV geometric deformation before TAVI may 
influence the prognosis after TAVI. LV fibrosis was an independent predictor of mortality for 
patients with severe aortic stenosis [24-27].
 
Furthermore, worse GLS was also associated 
with interstitial fibrosis in an animal model of hypertensive heart failure [28], thereby 
suggesting that pre-procedural GLS could be a predictor of clinical events after TAVI.  
Previous reports have shown that the pre-operative E/SR_E ratio was significantly 
associated with long-term post-operative survival in patients undergoing SAVR, although the 
E/SR_E ratio was not significantly different in patients with or without events in this study. 
This discrepancy might be explained by the different end-points of the two studies (mortality 
vs. events), since the mortality after TAVI was extremely low in our study. Further studies 
are needed for clarification. 
 
 
 
 
  
 
Study limitations 
There were several limitations to my study. First, this study included only a small 
number of patients with events. Therefore, multivariate analysis was not conducted. Second, 
there was no control group of matched patients with conventional SAVR, which limited our 
ability to assess the efficacy of TAVI. 
 
Conclusion 
    Preoperative LV geometric deformation and function, as a consequence of cumulative 
burden of pressure overload, could predict clinical outcomes after TAVI. 
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Table 1. Patient background 
  
 
 
 
 
 
 
 
  
 
Table 2. Echocardiographic data before after TAVI 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LVDd, left ventricular diastolic dimension; LVDs, left ventricular systolic dimension; IVS, Interventricular septum; 
PW, posterior wall; LVEF, left ventricular ejection fraction; LVMI, left ventricular mass index; Dct, deceleration 
time; AV, aortic valve; peak V, peak velocity; mean PG, mean pressure gradient; AVA, aortic valve area; GLS, 
global longitudinal strain; SR_E, early diastolic peak strain rate 
  
 
Table 3. Clinical and echocardiographic characteristics in 
patients with and without events 
 
 
 
 
 
 
 
 
 
 
 
 
CAD, coronary artery disease; HT, hypertension; CKD, chronic kidney disease; DM, diabetes mellitus; BNP, 
brain natriuretic peptide; LVDd, left ventricular dimension diastolic; LVDs, left ventricular dimension systolic; 
IVS, Interventricular septum; PW, posterior wall; LVEF, left ventricular ejection fraction; LVMI, left ventricular 
mass index; Dct, deceleration time; AV, aortic valve; peak V, peak velocity; mean PG, mean pressure gradient; 
AVA, aortic  valve area; AR, aortic regurgitation; MR, Mitral regurgitation;  TR, tricuspid regurgitation GLS, 
global longitudinal strain; SR_E, early diastolic peak strain rate 
  
 
Table 4. Univariate analysis of echocardiographic 
parameters for predicting event after TAVI 
 
 
 
 
 
 
 
 
 
 
 
 
LVDd, left ventricular diastolic dimension; LVDs, left ventricular systolic dimension;  
IVS, Interventricular septum; PW, posterior wall; LVEF, left ventricular ejection fraction; LVMI, left ventricular 
mass index; Dct, deceleration time; AV, aortic valve; mean PG, mean pressure gradient; AVA, aortic valve 
area; AR, aortic regurgitation; MR, Mitral regurgitation; TR, tricuspid regurgitation; GLS, global longitudinal 
strain; SR_E, early diastolic peak strain rate 
  
 
Fig 1. Receiver-operating characteristic (ROC) curves showing 
LV global longitudinal strain (GLS) for predicting events after 
transcatheter aortic valve implantation.  
 
AUC, area under the curve. 
 
 
  
 
Fig 2. Kaplan-Meier curves showing freedom from event 
after transcatheter aortic valve implantation. 
 
Event-free survival of patients with global longitudinal strain GLS < -10.6% compared to 
patients with GLS > -10.6%. 
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